Quire today announced the launch of its next-generation technology that provides healthcare organizations with a unique approach supporting value-based care. The technology uses artificial intelligence algorithms to quickly and flexibly develop predictive models from unstructured text in clinical notes and electronic medical records (EMRs). Quire’s approach enables providers to significantly increase the odds that their limited intervention resources are directed to the patients where care management teams can have maximum impact on the health and cost of a population.
Quire’s proven technology provides clinical and financial benefits to any health system, provider group or provider-sponsored health plan – especially those entering or renewing value-based contracts. With up to 80% of recorded patient data being unstructured, Quire enables providers to more accurately target patients to receive attention. Quire technology runs seamlessly alongside any EMR with no impact on provider workflow.
“Structured data analytics can be complex and time-consuming,” says Quire CEO Brad Silver. “In contrast, Quire swiftly searches through millions of physician notes and automatically makes inferences based on that information. Quire capitalizes on physicians practicing medicine like they traditionally have – documenting encounters in their notes where they can capture the nuances of each individual patient. The technology does the rest, helping healthcare organizations create high impact patient lists to better manage intervention resources, especially in a value-based environment.”
“Quire’s technology makes it much faster and easier to pinpoint the patients most likely to have hospital admissions and readmissions,” says Scott Fowler, MD, President and CEO of Holston Medical Group. “It’s a big advance over structured data analytics because it lets you identify what’s under the metrics. With Quire, we can get a handle on root causes, which can include behavioral and social issues in addition to medical complexities of chronic illnesses.”
“Quire also enables us to highlight rising-risk patients who may otherwise be overlooked. By not just focusing on the high-cost patients, we increase the odds of improving the long term health and cost of the population we’re managing,” adds Fowler.
Quire has developed a cutting-edge data analytics technology to support healthcare providers focused on value-based care. The technology not only identifies which groups of patients to target for intervention, but why. Artificial intelligence algorithms drive predictive models by combing through the deepest knowledge existing on patients, the unstructured text from providers’ clinical notes and electronic medical records (EMRs). The software enables healthcare providers to make more informed decisions about how and where to direct their limited intervention resources. Quire significantly increases the odds that resources are driven to optimal patients when the goal is managing the overall health and cost of the population. The privately held company, with headquarters in Memphis, Tennessee, is backed by veteran healthcare investors, including TriStar Technology Ventures, Innova and Pittco. To learn more, visit www.quiredata.com.